CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
114 hedge funds and large institutions have $423M invested in Concert Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
44% more funds holding
Funds holding: 79 → 114 (+35)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
114
Holding in Top 10
1
Calls
$1.22M
Puts
$769K
Top Buyers
| 1 | +$18.4M | |
| 2 | +$16.8M | |
| 3 | +$13M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$10.3M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.71M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$30.2M | |
| 3 | -$6.7M | |
| 4 |
SM
Senvest Management
New York
|
-$6.2M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.43M |